Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Radiation Oncology, Biology, Physics|June 5, 2012
Early salvage hormonal therapy for biochemical failure improved survival in prostate cancer patients after neoadjuvant hormonal therapy plus radiation therapy--a secondary analysis of irish clinical oncology research group 97-01Aminudin R Mydin, Mary T Dunne, Marie A Finn, et al.
The British Journal of Radiology|January 17, 2020
The effect of anaemia on normal tissue toxicity and survival outcomes in prostate cancer treated with radical radiotherapy and neo-adjuvant androgen deprivationLorna G Keenan, Nazir Ibrahim, Mary T Dunne, et al.
The British Journal of Radiology|June 12, 2018
A comparison of bladder volumes based on treatment planning CT and BladderScan® BVI 6100 ultrasound device in a prostate radiation therapy populationLaura Mullaney, Evelyn O'Shea, Mary T Dunne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2012
The effect of short term neo-adjuvant androgen deprivation on erectile function in patients treated with external beam radiotherapy for localised prostate cancer: an analysis of the 4- versus 8-month randomised trial (Irish Clinical Oncology Research Group 97-01)Patricia E Daly, Mary T Dunne, Carmel M O'Shea, et al.
Journal of Contemporary Brachytherapy|May 22, 2023
Validation of the bladder neck as an important organ at risk in prostate seed brachytherapy based on D2cc: A single-institution, retrospective reviewNeil D Wallace, Karen L Olden, Victoria S Brennan, et al.
Practical Radiation Oncology|September 7, 2014
A randomized trial comparing bladder volume consistency during fractionated prostate radiation therapyLaura M Mullaney, Evelyn O'Shea, Mary T Dunne, et al.
Acta Oncologica (Stockholm, Sweden)|June 25, 2014
Temporal patterns of late bowel and bladder radiotherapy toxicity in a randomised controlled trial assessing duration of neo-adjuvant hormones in prostate cancerAisling S Barry, Mary T Dunne, Ciara A Lyons, et al.
Journal of Medical Imaging and Radiation Oncology|August 31, 2021
Pragmatic use of short-course radiotherapy, chemotherapy and surgery for stage IV rectal cancer with locally advanced or symptomatic primary tumoursMartin J Higgins, Jurgen Mulsow, Oonagh Staunton, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2010
A randomized trial (Irish clinical oncology research group 97-01) comparing short versus protracted neoadjuvant hormonal therapy before radiotherapy for localized prostate cancerJohn G Armstrong, Charles M Gillham, Mary T Dunne, et al.
British Journal of Cancer|December 9, 2022
Efficacy and toxicity of primary re-irradiation for malignant spinal cord compression based on radiobiological modelling: a phase II clinical trialNeil D Wallace, Mary T Dunne, Orla McArdle, et al.
Pageof 2